Cizzle Biotechnology (UK) Performance
| CIZ Stock | 1.70 0.15 8.11% |
On a scale of 0 to 100, Cizzle Biotechnology holds a performance score of 2. The firm shows a Beta (market volatility) of -2.11, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cizzle Biotechnology are expected to decrease by larger amounts. On the other hand, during market turmoil, Cizzle Biotechnology is expected to outperform it. Please check Cizzle Biotechnology's value at risk, kurtosis, price action indicator, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Cizzle Biotechnology's price patterns will revert.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40 percent - Mugglehead | 01/09/2025 |
| Begin Period Cash Flow | 478 K |
Cizzle |
Cizzle Biotechnology Relative Risk vs. Return Landscape
If you would invest 180.00 in Cizzle Biotechnology Holdings on November 29, 2024 and sell it today you would earn a total of 5.00 from holding Cizzle Biotechnology Holdings or generate 2.78% return on investment over 90 days. Cizzle Biotechnology Holdings is generating 0.2173% of daily returns and assumes 5.9806% volatility on return distribution over the 90 days horizon. Simply put, 53% of stocks are less volatile than Cizzle, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Cizzle Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cizzle Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cizzle Biotechnology Holdings, and traders can use it to determine the average amount a Cizzle Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0363
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CIZ | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.98 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Cizzle Biotechnology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cizzle Biotechnology by adding it to a well-diversified portfolio.
Cizzle Biotechnology Fundamentals Growth
Cizzle Stock prices reflect investors' perceptions of the future prospects and financial health of Cizzle Biotechnology, and Cizzle Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cizzle Stock performance.
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 5.92 M | ||||
| Shares Outstanding | 396.39 M | ||||
| Price To Book | 8.49 X | ||||
| Price To Sales | 200.48 X | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (695) | ||||
| Net Income | (1.76 M) | ||||
| Total Debt | 186 K | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (639 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Total Asset | 1.69 M | ||||
| Retained Earnings | (7.87 M) | ||||
About Cizzle Biotechnology Performance
By analyzing Cizzle Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Cizzle Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cizzle Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cizzle Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cizzle Biotechnology is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Cizzle Biotechnology performance evaluation
Checking the ongoing alerts about Cizzle Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cizzle Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cizzle Biotechnology had very high historical volatility over the last 90 days | |
| Cizzle Biotechnology may become a speculative penny stock | |
| Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 25 K. | |
| Cizzle Biotechnology generates negative cash flow from operations | |
| About 44.0% of the company shares are held by company insiders |
- Analyzing Cizzle Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cizzle Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Cizzle Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cizzle Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cizzle Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cizzle Biotechnology's stock. These opinions can provide insight into Cizzle Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cizzle Stock analysis
When running Cizzle Biotechnology's price analysis, check to measure Cizzle Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cizzle Biotechnology is operating at the current time. Most of Cizzle Biotechnology's value examination focuses on studying past and present price action to predict the probability of Cizzle Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cizzle Biotechnology's price. Additionally, you may evaluate how the addition of Cizzle Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |